Patients with AD are characterized by the progressive accumulation of two neuropathological hallmarks of AD, amyloid-β (Aβ) and tau [2], which eventually lead to the severe impairment of cognition and behavior. This evidence concerns the gene MAPT and Alzheimer disease.